Skip to content
Back to event

KalshiKalshi· Science and Technology

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?

Chance

38%

Buy Yes

41¢

pays $1 if it happens

Buy No

64¢

pays $1 if it doesn’t

Prices from Kalshi, updated 14 minutes ago. Ends Jan 1, 4:59 AM UTC.

Price over the last 2 weeks
Cost of a Yes share
How this market is decidedShow

If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.